Onyx Pharmaceuticals to Present at UBS Global Life Sciences Conference

Onyx Pharmaceuticals to Present at UBS Global Life Sciences
Conference 


RICHMOND, Calif., Sept. 21  /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals,
Inc. (NASDAQ:ONXX) today announced that it will present at the UBS Global Life
Science conference on Monday, September 27, at 1:30 p.m. Eastern Time.
Interested parties may access a live webcast of the presentation at:

http://event.streamx.us/event/default.asp?event=ubs20040927

It is recommended that listeners log on 15 minutes early in order to register
and download any necessary software.  If you are unable to participate during
the live webcast, a recorded replay of the presentation will be available
within 24 hours of the completion of the presentation through October 27.

Onyx Pharmaceuticals is engaged in the development of novel cancer therapies
that target the molecular basis of cancer.  With its collaborators, the company
is developing small molecule drugs, including BAY 43-9006 with Bayer
Pharmaceuticals Corporation.  For more information about Onyx's pipeline and
activities, visit the company's website at http://www.onyx-pharm.com/. 

DATASOURCE: Onyx Pharmaceuticals, Inc.



CONTACT:  Julie Wood of Onyx Pharmaceuticals, Inc., [phone]



Web site:  http://www.onyx-pharm.com/ 

Copyright